alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the Innova
Corporation Form 10-Q for the period ended September 30, 1997 and is qualified
in its entirety by reference to such financial statements.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JUL-01-1997
<PERIOD-END>                               SEP-30-1997
<CASH>                                      32,245,196
<SECURITIES>                                         0
<RECEIVABLES>                                8,318,591
<ALLOWANCES>                                  (65,818)
<INVENTORY>                                  7,319,741
<CURRENT-ASSETS>                            47,866,503
<PP&E>                                      11,314,152
<DEPRECIATION>                             (3,491,219)
<TOTAL-ASSETS>                              55,924,045
<CURRENT-LIABILITIES>                        8,248,187
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                    88,862,176
<OTHER-SE>                                   2,796,487
<TOTAL-LIABILITY-AND-EQUITY>                55,924,045
<SALES>                                     10,418,475
<TOTAL-REVENUES>                            10,418,475
<CGS>                                        7,012,353
<TOTAL-COSTS>                                7,012,353
<OTHER-EXPENSES>                             3,101,494
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             170,255
<INCOME-PRETAX>                                389,558
<INCOME-TAX>                                   389,558
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   389,558
<EPS-PRIMARY>                                     0.02
<EPS-DILUTED>                                     0.02
        

</TABLE>
[No. 37429-0-I.

Division One.

December 8, 1997.]

#### The State of Washington, *Respondent,*v. Jermaine M. Williams, *Appellant.*

Appeal from a judgment of the Superior Court for King County, No. 96-8-05100-6, LeRoy McCullough, J., entered September 11, 1995. *Affirmed*by unpublished opinion per Grosse, J., concurred in by Agid and Ellington, JJ.
Michigan Supreme Court

Lansing, Michigan

Marilyn Kelly,

 Chief Justice

Michael F. Cavanagh

Elizabeth A. Weaver

Maura D. Corrigan

Robert P. Young, Jr.

Stephen J. Markman

Diane M. Hathaway, Justices

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the 

foregoing is a true and complete copy of the order entered at the direction of the Court. 

 _________________________________________ 

 Clerk

April 29, 2009 

p0422 

Order 

 

April 29, 2009 

137888 

ROBERT SAWYER WILLIAMS, TREVA 

WOMBLE and the ESTATE OF ROBERT 

SETON WILLIAMS, Robert Sawyer Williams, 

Personal Representative, 

Plaintiffs-Appellants, 

v SC: 137888 

 COA: 285920 

Wayne CC: 05-529848-NO 

SHEEHAN’S ON THE GREEN, INC., and 

ESTATE OF ADAM GRADINSCAK, 

Walter Sakowski, Personal Representative, 

Defendants-Appellees. 

_________________________________________/ 

On order of the Court, the application for leave to appeal the November 3, 2008 

order of the Court of Appeals is considered, and it is DENIED, because we are not 

persuaded that the questions presented should be reviewed by this Court.
##### 



EXHIBIT 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. § 1350, as adopted pursuant to §906 of the Sarbanes-Oxley
Act of 2002, I, David H. Thompson, Chief Financial Officer, certify that:

1.     I have read this quarterly report on Form 10-QSB of International
Absorbents, Inc.;

2.     To my knowledge, this report fully complies with the requirements of
section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

3.     To my knowledge, the information in this report fairly presents, in all
material respects, the financial condition and results of operations as of
October 31, 2003.

Date: December 10, 2003



| | /s/ David H. Thompson
David H. Thompson
Chief Financial Officer
| | ---------------------------------------------------------------

Assigned original of this written statement required by section 906 has been
provided to International Absorbents Inc. and will be retained by International
Absorbents Inc. and furnished to the Securities and Exchange Commission or its
staff upon request. This certification is accompanying the Form 10-QSB solely
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and is not being
filed as part of the Form 10-QSB or as a separate disclosure document.

27
<PAGE>   1

                                                                    Exhibit 24.2

                                POWER OF ATTORNEY


         KNOW ALL MEN BY THESE PRESENTS, the person whose signature appears
below constitutes and appoints Yehoram Uziel attorney-in-fact, for him, with the
power of substitution, in any and all capacities, to sign the Registration
Statement on Form S-8 for 1,500,000 shares issuable under the Soligen
Technologies, Inc. 1993 Stock Option Plan, as amended, and any amendments to
such Registration Statement (including post-effective amendments), and to file
exhibits thereto and other documents in connection therewith with the Securities
and Exchange Commission, granting unto said attorney-in-fact full power and
authority to do or perform each and every act and thing requisite or necessary
to be done in and about the premises, as fully to all intents and purposes as he
might or could do in person, hereby ratifying and confirming all that said
attorney-in-fact or substitute may lawfully do or cause to be done by virtue
hereof.


                                             /s/ Kenneth T. Friedman
                                             -----------------------------------
                                             Kenneth T. Friedman
###### Editorial Note on Part 25

#### Editorial Note:

Nomenclature changes to part 25 appear at 79 FR 75879, Dec. 19, 2014.

#### § 25.432 Highest level owner.

*Highest level owner* has the meaning given in 2 CFR 200.1.
##### 



EXHIBIT 31.1
 CERTIFICATION PURSUANT TO
EXCHANGE ACT RULE 13a-14(a)
  1.
    
    I have reviewed this Report on Form 10-Q of International Absorbents Inc.;2.
    
    Based on my knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this report;3.
    
    Based on my knowledge, the financial statements, and other financial information included in
this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this
report;4.
    
    The registrants other certifying officer(s) and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) for the registrant and have:
 (a)
    
    Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries, is
made known to us by others within those entities, particularly during the period in
which this report is being prepared;(b)
    
    Evaluated the effectiveness of the registrants disclosure controls and
procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report
based on such evaluation; and(c)
    
    Disclosed in this report any change in the registrants internal control over
financial reporting that occurred during the registrants most recent fiscal quarter
(the registrants fourth fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect, the registrants
internal control over financial reporting; and
 5.
    
    The registrants other certifying officer(s) and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and the
audit committee of the registrants board of directors (or persons performing the equivalent
functions):
 (a)
    
    All significant deficiencies and material weaknesses in the design or operation
of internal control over financial reporting which are reasonably likely to adversely
affect the registrants ability to record, process, summarize and report financial
information; and(b)
    
    Any fraud, whether or not material, that involves management or other employees
who have a significant role in the registrants internal control over financial
reporting.
 Date: December 8, 2006
    
    /s/ GORDON ELLISGordon EllisPresident and Chief Executive Officer
Exhibit 31.1



FORM 10-KSB CERTIFICATION



CERTIFICATION PURSUANT TO RULE 13a-14(a) AND 15d-14(a) 
OF THE SECURITIES EXCHANGE ACT OF 1934, 
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANE-OXLEY ACT.





|I, James R. Arabia, certify that:
|---------------------------------
|                                 
|1.                               
|                                 
|2.                               
|                                 
|3.                               
|                                 
|4.                               
|                                 
|                                 
|                                 
|                                 
|                                 
|                                 
|                                 
|                                 
|                                 
|5.                               
|                                 
|                                 
|                                 
|                                 
|                                 
|                                 
|Date: October 12, 2005           
|
Exhibit 99.1

Anaren Acquires RF Power Components, Inc. And Announces 3 for 2 Stock Split

      SYRACUSE,  N.Y.,  March 2  /PRNewswire/  -- Anaren  Microwave,  Inc. today
announced  that it has acquired all the  outstanding  capital  stock of RF Power
Components, Inc., a privately held Long Island, New York based Company. RF Power
is a leading  manufacturer  of coaxial and surface mount RF power  resistors and
attenuators  used  primarily  in  the  wireless   communications  market.  "This
acquisition  strengthens  and expands  Anaren's  microwave  power  product  line
enabling the Company to more broadly  serve our  Wireless OEM  customers,"  said
Lawrence A. Sala,  Anaren  President and CEO. This acquisition will be accounted
for as a purchase transaction.

      Anaren also  announced  today that the  Company's  Board of Directors  has
authorized  a  three-for-two  stock  split,  to be  effected in the form of a 50
percent  stock  dividend  payable  to  shareholders  of record on May 12,  2000.
Certificates  representing the additional shares resulting from the dividend are
expected to be mailed on or June 9, 2000.

      Statements  contained  in this  news  release  which  are  not  historical
information  are  "forward-looking  statements"  pursuant  to  the  safe  harbor
provisions  of the  Private  Securities  Litigation  Reform  Act of 1995.  These
statements  involve risks and uncertainties that are described in more detail in
Anaren's annual report and in Anaren's Form 10-K and 10-Q reports,  and exhibits
to those  reports  filed with the  Securities  and Exchange  Commission.  Anaren
designs,   develops,   manufactures  and  sells  highly   integrated   microwave
components, assemblies and subsystems for the wireless communications, satellite
communications and defense electronics markets.
Exhibit 32

                   Certification of Periodic Financial Report

                       Pursuant to 18 U.S.C. Section 1350

Pursuant to 18 U.S.C.  Section 1350,  as adopted  pursuant to Section 906 of the
Sarbanes-Oxley  Act  of  2002,  each  of  the  undersigned   officers  of  AMCOL
International Corporation (the "Company") certifies that the quarterly report on
Form 10-Q of the Company for the six months  ended June 30, 2004 fully  complies
with the  requirements of Section 13(a) or 15(d) of the Securities  Exchange Act
of 1934 and  information  contained  in that Form 10-Q fairly  presents,  in all
material  respects,  the  financial  condition  and results of operations of the
Company.

Date:  August 6, 2004

                                         --------------------------------------
                                         Lawrence E. Washow
                                         Chief Executive Officer



Date:  August 6, 2004

                                         --------------------------------------
                                         Gary L. Castagna
                                         Chief Financial Officer
§ 250.12 Stramonium preparations labeled with directions for use in self-medication regarded as misbranded. ( a ) Stramonium products for inhalation have been offered for use in the therapy of the acute attacks of bronchial asthma for many years although their reliability and effectiveness are questionable. Recently, a significantly increased number of reports have come to the attention of the Food and Drug Administration showing that such products have been subject to abuse and misuse on a fairly large scale, mostly by young people, through oral ingestion for the purpose of producing hallucinations. Reports of such use have been received from physicians and police and other law enforcement authorities. Reports have also appeared in the public press and in medical journals.
( b ) Labeling these products with a warning that they are not for oral ingestion has not been effective in protecting the public. Misuse of stramonium preparations can cause serious toxic effects including toxic delirium, visual disturbances, fever, and coma. A number of serious reactions have already occurred from the oral ingestion of such products.
( c ) On the basis of this information, the Commissioner of Food and Drugs has concluded that such articles have a potentiality for harmful effect through misuse and are not safe for use except under the supervision of a physician. In the interest of public health protection, therefore, the Food and Drug Administration adopts the following policy: ( 1 ) Preparations containing stramonium supplied from the leaves, seeds, or any other part of the plant in the form of a powder, pipe mixture, cigarette, or any other form, with or without admixture of other ingredients, will be regarded as misbranded if they are labeled with directions for use in self-medication.
( 2 ) The Food and Drug Administration will, on request, furnish comment on proposed labeling limiting any such preparation to prescription sale.
( d ) The labeling or dispensing of stramonium preparations contrary to this statement after 60 days following the date of its publication in the Federal Register may be made the subject of regulatory proceedings.
[No. 39103-8-I.

Division One.

November 10, 1997.]

#### The State of Washington, *Respondent,*v. Ralph Martin Hunter, *Appellant.*

Appeal from a judgment of the Superior Court for King County, No. 96-1-00157-7, Ann Schindler, J., entered July 8, 1996. *Affirmed*by unpublished opinion per Kennedy, A.C.J., concurred in by Coleman and Webster, JJ.
# L_2018166EN.01000101.xml

| 3.7.2018 | EN | Official Journal of the European Union | L 166/1 |
| --- | --- | --- | --- |

3.7.2018

EN

Official Journal of the European Union

L 166/1

---

COMMISSION IMPLEMENTING REGULATION (EU) 2018/938

of 20 June 2018

entering a name in the register of protected designations of origin and protected geographical indications (‘Choucroute d'Alsace’ (PGI))

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 1151/2012 of the European Parliament and of the Council of 21 November 2012 on quality schemes for agricultural products and foodstuffs (1), and in particular Article 52(2) thereof,

Whereas:

| (1) | Pursuant to Article 50(2)(a) of Regulation (EU) No 1151/2012, France's application to register the name ‘Choucroute d'Alsace’ was published in the Official Journal of the European Union (2). |
| --- | --- |

(1)

Pursuant to Article 50(2)(a) of Regulation (EU) No 1151/2012, France's application to register the name ‘Choucroute d'Alsace’ was published in the Official Journal of the European Union (2).

| (2) | As no statement of opposition under Article 51 of Regulation (EU) No 1151/2012 has been received by the Commission, the name ‘Choucroute d'Alsace’ should therefore be entered in the register, |
| --- | --- |

(2)

As no statement of opposition under Article 51 of Regulation (EU) No 1151/2012 has been received by the Commission, the name ‘Choucroute d'Alsace’ should therefore be entered in the register,

HAS ADOPTED THIS REGULATION:

Article 1

The name ‘Choucroute d'Alsace’ (PGI) is hereby entered in the register.

The name specified in the first paragraph denotes a product in Class 1.6. Fruit, vegetables and cereals, fresh or processed, as listed in Annex XI to Commission Implementing Regulation (EU) No 668/2014 (3).

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 20 June 2018.

For the Commission,

On behalf of the President,

Phil HOGAN

Member of the Commission

---

(1)  
  OJ L 343, 14.12.2012, p. 1.

1

(2)  
  OJ C 51, 10.2.2018, p. 29.

2

(3)  Commission Implementing Regulation (EU) No 668/2014 of 13 June 2014 laying down rules for the application of Regulation (EU) No 1151/2012 of the European Parliament and of the Council on quality schemes for agricultural products and foodstuffs (OJ L 179, 19.6.2014, p. 36).

3

---
§ 1313.42 Prohibition of shipments from certain foreign sources. ( a ) If the Administrator determines that a foreign manufacturer or distributor of ephedrine, pseudoephedrine, or phenylpropanolamine has refused to cooperate with a request by the Administrator for information known to the manufacturer or distributor on the distribution of the chemical, including sales, the Administrator may issue an order prohibiting the importation of the chemical in any case where the manufacturer or distributor is part of the chain of distribution.
( b ) Not later than 60 days prior to issuing the order to prohibit importation, the Administrator shall publish in the Federal Register a notice of intent to issue the order. During the 60-day period, imports from the foreign manufacturer or distributor may not be restricted under this section.
[75 FR 10172, Mar. 5, 2010]
#### § 1.1375 What information submitted in a petition requesting modified requirements or an exemption, or information in comments on such a petition, is publicly available?

FDA will presume that information submitted in a petition requesting modified requirements or an exemption, as well as information in comments submitted on such a petition, does not contain information exempt from public disclosure under part 20 of this chapter and will be made public as part of the docket associated with the petition.
# L_2018237EN.01001201.xml

| 20.9.2018 | EN | Official Journal of the European Union | L 237/12 |
| --- | --- | --- | --- |

20.9.2018

EN

Official Journal of the European Union

L 237/12

---

Corrigendum to Commission Implementing Regulation (EU) 2018/553 of 3 April 2018 concerning the classification of certain goods in the Combined Nomenclature

(
  Official Journal of the European Union L 92 of 10 April 2018
  )

On page 1, in recital 5:

for:

‘The measures provided for in this Regulation are in accordance with the opinion of the Customs Code Committee,’,

read:

‘The Customs Code Committee has not delivered an opinion within the time limit laid down by its Chair,’.

---
# L_2018316EN.01000501.xml

| 13.12.2018 | EN | Official Journal of the European Union | L 316/5 |
| --- | --- | --- | --- |

13.12.2018

EN

Official Journal of the European Union

L 316/5

---

COMMISSION IMPLEMENTING REGULATION (EU) 2018/1966

of 6 December 2018

conferring protection under Article 99 of Regulation (EU) No 1308/2013 of the European Parliament and of the Council on the name ‘Uhlen Laubach’ (PDO)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 1308/2013 of the European Parliament and of the Council of 17 December 2013 establishing a common organisation of the markets in agricultural products and repealing Council Regulations (EEC) No 922/72, (EEC) No 234/79, (EC) No 1037/2001 and (EC) No 1234/2007 (1), and in particular Article 99 thereof,

Whereas:

| (1) | In accordance with Article 97(2) and (3) of Regulation (EU) No 1308/2013, the Commission has examined the application to register the name ‘Uhlen Laubach’ sent by Germany and has published it in the Official Journal of the European Union (2). |
| --- | --- |

(1)

In accordance with Article 97(2) and (3) of Regulation (EU) No 1308/2013, the Commission has examined the application to register the name ‘Uhlen Laubach’ sent by Germany and has published it in the Official Journal of the European Union (2).

| (2) | No statement of objection has been received by the Commission under Article 98 of Regulation (EU) No 1308/2013. |
| --- | --- |

(2)

No statement of objection has been received by the Commission under Article 98 of Regulation (EU) No 1308/2013.

| (3) | In accordance with Article 99 of Regulation (EU) No 1308/2013, the name ‘Uhlen Laubach’ should be protected and entered in the register referred to in Article 104 of that Regulation. |
| --- | --- |

(3)

In accordance with Article 99 of Regulation (EU) No 1308/2013, the name ‘Uhlen Laubach’ should be protected and entered in the register referred to in Article 104 of that Regulation.

| (4) | The measures provided for in this Regulation are in accordance with the opinion of the Committee for the Common Organisation of the Agricultural Markets, |
| --- | --- |

(4)

The measures provided for in this Regulation are in accordance with the opinion of the Committee for the Common Organisation of the Agricultural Markets,

HAS ADOPTED THIS REGULATION:

Article 1

The name ‘Uhlen Laubach’ (PDO) is hereby protected.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 6 December 2018.

For the Commission,

On behalf of the President,

Phil HOGAN

Member of the Commission

---

(1)  
  OJ L 347, 20.12.2013, p. 671.

1

(2)  
  OJ C 277, 7.8.2018, p. 13.

2

---